Cargando…
The Developmental and Translational Study on Biomarkers and Clinical Characteristics-based Diagnostic and Therapeutic Identification of Major Depressive Disorder: Study Protocol for a Multicenter Randomized Controlled Trial in China
BACKGROUND: Major depressive disorder (MDD) is a heterogeneous mental disease that encompasses different subtypes and specifiers. Clinically targeted treatments have not been identified yet, although standardized strategies are recommended by several clinical guidelines. The main aim of this study i...
Autores principales: | Liu, Xiaohua, Wang, Yun, Peng, Daihui, Zhang, Huifeng, Zheng, Yanqun, Wu, Yan, Su, Yun-Ai, Liu, Ming, Ma, Xiancang, Li, Yi, Shi, Jianfei, Cheng, Xiaojing, Rong, Han, Fang, Yiru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553657/ https://www.ncbi.nlm.nih.gov/pubmed/33116533 http://dx.doi.org/10.2147/NDT.S271842 |
Ejemplares similares
-
A Preliminary Study of Different Treatment Strategies for Anxious Depression
por: Wang, Yun, et al.
Publicado: (2022) -
A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
por: Wang, Yun, et al.
Publicado: (2021) -
TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms
por: Liu, Hongmei, et al.
Publicado: (2022) -
P300 event-related potentials in patients with different subtypes of depressive disorders
por: Wang, Yun, et al.
Publicado: (2023) -
A Study of Individualized Diagnosis and Treatment for Depression with Atypical Features (iDoT-AFD): study protocol for a randomized clinical trial and prognosis study
por: Zhou, Rubai, et al.
Publicado: (2023)